![]() | License: Creative Commons Attribution 4.0 PDF - Published Version (559kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-541946
- DOI to cite this document:
- 10.5283/epub.54194
Abstract
Background and objectiveMetamizole is a non-opioid ampyrone sulfonate compound with potent analgesic, antipyretic, and spasmolytic effects. Agranulocytosis is a rare life-threatening complication of metamizole.CaseHere, we present the case of a 62-year-old patient who developed agranulocytosis as well as hemolysis after a single administration of metamizole.ConclusionThis case illustrates the inherent allergic potential of metamizole and its effects on different hematopoietic cell types.